Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
MRT-5421 by Sanofi for Unspecified Influenza Virus Infections: Likelihood of Approval
MRT-5421 is under clinical development by Sanofi and currently in Phase II for Unspecified Influenza Virus Infections. According to GlobalData,...